MedPath
NMPA Approval

Heparolysate Injection

国药准字H20045916

December 10, 2020

Drug Information

肝水解肽注射液

注射剂

5ml:50mg

化学药品

December 10, 2020

Company Information

Applicant Company

长春市高新开发区创新路358号

Manufacturing Company

长春市高新开发区创新路358号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.